Complement C4d Antibody (C4D204), Novus Biologicals™

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP2342340.2MG

Catalog No. NBP234234B

Description

Complement C4d Monoclonal antibody specifically detects Antigen in Human samples. It is validated for Immunocytochemistry/Immunofluorescence, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin).

Specifications

• Antigen: Complement C4d
• Classification: Monoclonal
• Conjugate: Unconjugated
• Formulation: PBS with 0.05% BSA. with 0.05% Sodium Azide
• Gene Symbols: C4A
• Immunogen: Recombinant human Complement 4d protein
• Purification Method: Protein A purified
• Regulatory Status: RUO
• Gene ID (Entrez): 720
• Target Species: Human
• Form: Purified

• Applications: Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen)
• Clone: C4D204
• Dilution: Immunocytochemistry/Immunofluorescence 1:50-1:100, Immunohistochemistry-Paraffin 1:200-1:400, Immunohistochemistry-Frozen 1:200-1:400
• Gene Accession No.: P0C0L4
• Host Species: Mouse
• Molecular Weight of Antigen: 192 kDa
• Quantity: 0.2 mg
• Primary or Secondary: Primary
• Test Specificity: This MAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d.C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.
• Content And Storage: Store at 4C.
• Isotype: IgG1 κ